๐Ÿงช Beta โ€” BiohacksAI is under active development. Data and features may change.
B
BiohacksAI
Evidence-Based Biohacking
BetaPatent Pending

Bergapten

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Bergapten, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

1-(5,8-dihydro-1,4-dihydroxy-5,8-dioxo-2-naphthyl)-4-methylpent-3-en-1-yl
2 shared targets
plumbagin
2 shared targets
chrysin
2 shared targets
Apigenin
2 shared targets
Luteolin
2 shared targets
myricetin-3-O-galactopyranoside
2 shared targets
Quercetin
2 shared targets
Loading evidence profile...

This evidence profile for Bergapten is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.